BUSM researchers have discovered that the anti-seizure drug ezogabine, reduced alcohol consumption...
ASN Recognizes BUSM’s Salant as Leader in Fight against Kidney Disease
David J. Salant, MD, a professor of medicine at Boston University School of Medicine, chief of nephrology at Boston Medical Center, will be recognized by the American Society of Nephrology (ASN) as a leader in the fight against kidney disease, the eighth leading cause of death in the U.S. He will be awarded the John P. Peters Award on Saturday, Nov. 9, during the ASN Kidney Week in Atlanta, for his work on the mechanisms of immune deposition and the role of complement in glomerular diseases as well as the structural biology of the podocyte.
The John P. Peters Award recognizes individuals who have made substantial research contributions to the discipline of nephrology and have sustained achievements in one or more domains of academic medicine including clinical care, education and leadership.
Supported by grants from the National Institutes of Health, Salant has conducted extensive research on immune disorders of the kidneys. He was one of the earliest proponents of the notion that podocyte injury forms the basis of most, if not all, proteinuric kidney diseases. He was among the first to identify the podocyte as the primary target of injury in antibody-mediated glomerular disease.